X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32593) 32593
Newspaper Article (3618) 3618
Newsletter (1885) 1885
Magazine Article (331) 331
Book Chapter (239) 239
Book / eBook (125) 125
Trade Publication Article (46) 46
Web Resource (37) 37
Dissertation (35) 35
Publication (26) 26
Book Review (22) 22
Transcript (21) 21
Reference (18) 18
Government Document (15) 15
Conference Proceeding (13) 13
Streaming Video (10) 10
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24142) 24142
science & technology (21065) 21065
life sciences & biomedicine (20268) 20268
fractures (20074) 20074
female (16237) 16237
osteoporosis (12962) 12962
male (12586) 12586
aged (11301) 11301
middle aged (9754) 9754
risk factors (9016) 9016
orthopedics (8234) 8234
adult (6125) 6125
bone density (5812) 5812
aged, 80 and over (5631) 5631
medicine & public health (5001) 5001
surgery (4935) 4935
endocrinology & metabolism (4930) 4930
research (4779) 4779
bones (4192) 4192
health aspects (3934) 3934
fractures, bone - prevention & control (3921) 3921
care and treatment (3564) 3564
treatment outcome (3318) 3318
prevention (3141) 3141
fractures, bone - etiology (3037) 3037
adolescent (3024) 3024
rheumatology (2925) 2925
retrospective studies (2924) 2924
general & internal medicine (2797) 2797
analysis (2693) 2693
bone density conservation agents - therapeutic use (2572) 2572
fracture (2520) 2520
endocrinology (2519) 2519
bone mineral density (2498) 2498
fractures, bone - epidemiology (2409) 2409
osteoporosis - drug therapy (2305) 2305
density (2295) 2295
osteoporosis - complications (2231) 2231
older people (2204) 2204
patients (2172) 2172
child (2170) 2170
medicine, general & internal (2153) 2153
incidence (2143) 2143
animals (2128) 2128
risk assessment (2115) 2115
vitamin d (2097) 2097
radiography (2014) 2014
bone density - drug effects (1965) 1965
prospective studies (1895) 1895
follow-up studies (1892) 1892
studies (1790) 1790
medicine (1773) 1773
hip joint (1733) 1733
injuries (1720) 1720
epidemiology (1716) 1716
medical research (1689) 1689
osteoporosis - prevention & control (1648) 1648
young adult (1633) 1633
trauma (1606) 1606
diphosphonates - therapeutic use (1604) 1604
mortality (1568) 1568
age (1530) 1530
women (1528) 1528
osteoporosis, postmenopausal - drug therapy (1516) 1516
time factors (1511) 1511
health risk assessment (1486) 1486
drug therapy (1468) 1468
postmenopausal women (1464) 1464
womens health (1451) 1451
hip fracture (1430) 1430
age factors (1413) 1413
abridged index medicus (1398) 1398
complications and side effects (1393) 1393
osteoporotic fractures - prevention & control (1378) 1378
absorptiometry, photon (1338) 1338
bone density - physiology (1335) 1335
medicine, experimental (1320) 1320
diagnosis (1299) 1299
research article (1284) 1284
hip (1259) 1259
bisphosphonates (1252) 1252
osteoporosis - diagnosis (1250) 1250
hip fractures - epidemiology (1248) 1248
osteoporosis - epidemiology (1242) 1242
usage (1216) 1216
fractures, bone - surgery (1212) 1212
fracture fixation, internal - methods (1198) 1198
clinical trials (1189) 1189
osteoporosis, postmenopausal - complications (1175) 1175
cohort studies (1159) 1159
falls (1148) 1148
child, preschool (1135) 1135
bone (1134) 1134
geriatrics & gerontology (1109) 1109
hip fractures - prevention & control (1102) 1102
pain (1088) 1088
exercise (1043) 1043
original (1041) 1041
hospitals (1039) 1039
internal medicine (1030) 1030
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (30) 30
Gerstein Science - Stacks (27) 27
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Sunnybrook Health Sciences Centre - Holland Stacks (5) 5
St. Michael's Hospital - Stacks (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Dentistry (Harry R Abbott) - Stacks (3) 3
Providence Healthcare - Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (2) 2
Providence Healthcare - Reference (2) 2
West Park Healthcare Centre - Stacks (2) 2
Baycrest Hospital - Oversize (1) 1
Credit Valley Hospital - Reference (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Trillium Health Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (36657) 36657
German (996) 996
Japanese (617) 617
French (407) 407
Russian (199) 199
Spanish (145) 145
Chinese (130) 130
Portuguese (113) 113
Italian (86) 86
Polish (65) 65
Danish (53) 53
Dutch (49) 49
Hungarian (42) 42
Swedish (36) 36
Czech (33) 33
Norwegian (32) 32
Turkish (32) 32
Croatian (29) 29
Korean (27) 27
Finnish (16) 16
Hebrew (13) 13
Persian (9) 9
Serbian (7) 7
Romanian (6) 6
Slovenian (6) 6
Arabic (4) 4
Ukrainian (4) 4
Bulgarian (3) 3
Latvian (3) 3
Bosnian (2) 2
Slovak (2) 2
Afrikaans (1) 1
Belarusian (1) 1
Greek (1) 1
Indonesian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 15, pp. 1417 - 1427
BACKGROUND Romosozumab is a monoclonal antibody that binds to and inhibits sclerostin, increases bone formation, and decreases bone resorption... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Risk | Bone Remodeling - drug effects | Alendronate - therapeutic use | Incidence | Spinal Fractures - prevention & control | Female | Drug Therapy, Combination | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - pharmacology | Alendronate - adverse effects | Bone Density - drug effects | Alendronate - pharmacology | Least-Squares Analysis | Aged | Cardiovascular Diseases - chemically induced | Fractures, Bone - prevention & control | Treatment outcome | Care and treatment | Fractures | Growth | Analysis | Monoclonal antibodies | Bones | Research | Jaw | Femur | Vertebrae | Immunoglobulins | Inhibitor drugs | Osteonecrosis | SOST protein | Bisphosphonates | Hip | Post-menopause | Bone resorption | Osteoporosis | Alendronic acid | Bone growth | Bone density | Drug therapy | Osteogenesis | randomized-trial | metaanalysis | disease | postmenopausal women | strength | bone-mineral density | Klinisk medicin | vertebral fractures | sclerosteosis | Clinical Medicine | aorta | risk
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2009, Volume 361, Issue 8, pp. 756 - 765
Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2009, Volume 361, Issue 8, pp. 745 - 755
Men receiving androgen-deprivation therapy for nonmetastatic prostate cancer are at high risk for bone loss and fractures... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lumbar Vertebrae - injuries | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Male | Osteoporosis - drug therapy | Prostatic Neoplasms - physiopathology | Bone Remodeling - drug effects | Incidence | Antibodies, Monoclonal, Humanized | Spinal Fractures - prevention & control | RANK Ligand - pharmacology | Injections, Subcutaneous | Aged, 80 and over | RANK Ligand - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Lumbar Vertebrae - physiology | Prostatic Neoplasms - drug therapy | RANK Ligand - adverse effects | Osteoporosis - chemically induced | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Prostatic Neoplasms - surgery | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Lumbar Vertebrae - drug effects | Denosumab | Bone Density Conservation Agents - pharmacology | Orchiectomy | Bone Density - drug effects | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Fractures, Bone - prevention & control | Osteoporosis | Bone density | Prostate cancer | Older people | Men | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2018, Volume 379, Issue 25, pp. 2407 - 2416
Journal Article